Effwa Infra and Research IPO vs Emcure Pharma IPO

Comparision between Effwa Infra and Research IPO and Emcure Pharma IPO.

IPO Details

Effwa Infra and Research IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Effwa Infra and Research IPO	Emcure Pharma IPO
Logo
Issue Category	SME	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	NSE SME	BSE, NSE
Lead Managers	Shreni Shares Limited	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Bigshare Services Pvt Ltd	Link Intime India Private Ltd
Market Maker	Rikhav Securities Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Effwa Infra and Research IPO is up to ₹51.27 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Effwa Infra and Research IPO is ₹82.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Effwa Infra and Research IPO	Emcure Pharma IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹78.00 per share	₹960.00 per share
Issue Price (Upper)	₹82.00 per share	₹1,008.00 per share
Issue Price (Final)	₹82.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)		₹90.00 per share
Market Lot Size	1600 shares	14 shares
Fresh Issue Size	53,16,800 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹43.60 Cr	up to ₹800.00 Cr
OFS Issue Size	9,36,000 shares	1,14,28,839 shares
OFS Issue Size (Amount)	up to ₹7.68 Cr	up to ₹1,152.03 Cr
Issue Size Total	62,52,800 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹51.27 Cr	up to ₹1,952.03 Cr

IPO Timetable

Effwa Infra and Research IPO opens on Jul 05, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Effwa Infra and Research IPO and Emcure Pharma IPO is Jul 09, 2024, and Jul 05, 2024, respectively.

	Effwa Infra and Research IPO	Emcure Pharma IPO
Anchor Bid Date	Jul 04, 2024	Jul 02, 2024
Issue Open	Jul 05, 2024	Jul 03, 2024
Issue Close	Jul 09, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Jul 10, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Jul 11, 2024	Jul 09, 2024
Credit of Share (Tentative)	Jul 11, 2024	Jul 09, 2024
Listing date (Tentative)	Jul 12, 2024	Jul 10, 2024
Anchor Lockin End date 1	Aug 09, 2024	Aug 07, 2024
Anchor Lockin End date 2	Oct 08, 2024	Oct 06, 2024

Financials

Effwa Infra and Research IPO P/E ratio is 10.59, as compared to Emcure Pharma IPO P/E ratio of 34.55.

Effwa Infra and Research IPO

Emcure Pharma IPO

Financial

Effwa Infra & Research Limited Financial Information (Restated)

Effwa Infra & Research Limited's revenue increased by 26.08% and profit after tax (PAT) rose by 169% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	8,302.83	6,478.54	4,648.21
Revenue	14,551.46	11,541.36	10,461.67
Profit After Tax	1,380.06	513.04	459.99
Net Worth	3,715.05	2,355.89	1,842.85
Reserves and Surplus	1,932.01	2,123.32	1,610.28
Total Borrowing	1,406.44	1,623.01	1,026.11
Amount in ₹ Lakhs

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

99.99%

98.90%

Promoter Shareholding (Post-Issue)

72.99%

78.24%

P/E Ratio

10.59

34.55

Market Cap

₹189.81 Cr.

₹19029.89 Cr.

ROE

45.46%%

16.90%%

ROCE

40.99%%

19.37%%

Debt/Equity

0.38

0.67

EPS

₹7.74

₹29.17

RoNW

37.15%%

16.87%%

Shares Offered

In the Effwa Infra and Research IPO retail investors (RII) are offered 20,91,200 shares while in Emcure Pharma IPO retail investors are offered 20,91,200 shares. Qualified institutional buyers (QIB) are offered 11,68,000 shares in Effwa Infra and Research IPO and 38,53,234 shares in Emcure Pharma IPO.

	Effwa Infra and Research IPO	Emcure Pharma IPO
Anchor Investor Reserveration	17,48,800 shares	57,79,850 shares
Market Maker Reserveration	3,24,800 shares
QIB	11,68,000 shares	38,53,234 shares
NII	9,20,000 shares	28,89,926 shares
RII	20,91,200 shares	67,43,160 shares
Employee	0 shares	1,08,900 shares
Others
Total	41,79,200 shares	1,37,03,538 shares

Bids Received (Subscription)

Effwa Infra and Research IPO subscribed 313.65x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Effwa Infra and Research IPO	Emcure Pharma IPO
QIB (times)	166.56x	191.24x
NII (times)	477.27x	49.32x
Big NII (times)		54.90x
Small NII (times)		38.16x
RII (times)	323.81x	7.36x
Employee (times)		8.81x
Other (times)
Total (times)	313.65x	67.87x

Compare with others

Effwa Infra and Research IPO	Emcure Pharma IPO
Prizor Viztech IPO	Brainbees Solutions (Firstcry) IPO
Sati Poly Plast IPO	Ceigall India IPO
Sahaj Solar IPO	Akums Drugs and Pharmaceuticals IPO
Aelea Commodities IPO	Sanstar IPO
Ganesh Green Bharat IPO	Bansal Wire IPO
Ambey Laboratories IPO	OLA Electric IPO
Nephro Care India IPO	Vraj Iron and Steel IPO
Diensten Tech IPO	Aasaan Loans IPO
Visaman Global Sales IPO	Stanley Lifestyles IPO
Mason Infratech IPO	DEE Piping Systems IPO

Comments

Add a public comment...